Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Metformin and Long Non-Coding Rnas in Breast Cancer Publisher Pubmed



Gholami M1, 2 ; Klashami ZN1 ; Ebrahimi P3 ; Mahboobipour AA4 ; Farid AS2 ; Vahidi A1 ; Zoughi M2 ; Asadi M5 ; Amoli MM1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Metabolic Disorders Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Arcavacata, Italy
  4. 4. School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Metabolomics and Genomics Research Center Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

Source: Journal of Translational Medicine Published:2023


Abstract

Breast cancer (BC) is the second most common cancer and cause of death in women. In recent years many studies investigated the association of long non-coding RNAs (lncRNAs), as novel genetic factors, on BC risk, survival, clinical and pathological features. Recent studies also investigated the roles of metformin treatment as the firstline treatment for type 2 diabetes (T2D) played in lncRNAs expression/regulation or BC incidence, outcome, mortality and survival, separately. This comprehensive study aimed to review lncRNAs associated with BC features and identify metformin-regulated lncRNAs and their mechanisms of action on BC or other types of cancers. Finally, metformin affects BC by regulating five BC-associated lncRNAs including GAS5, HOTAIR, MALAT1, and H19, by several molecular mechanisms have been described in this review. In addition, metformin action on other types of cancers by regulating ten lncRNAs including AC006160.1, Loc100506691, lncRNA-AF085935, SNHG7, HULC, UCA1, H19, MALAT1, AFAP1-AS1, AC026904.1 is described. © 2023, The Author(s).
Related Docs
View other Related Docs
1. Long Noncoding Rnas and Exosomal Lncrnas: Classification, and Mechanisms in Breast Cancer Metastasis and Drug Resistance, Oncogene (2020)
2. Critical Roles of Long Noncoding Rnas in Breast Cancer, Journal of Cellular Physiology (2020)
3. An Overview of Long Noncoding Rnas: Biology, Functions, Therapeutics, Analysis Methods, and Bioinformatics Tools, Cell Biochemistry and Function (2022)
4. The Effect of Metformin on Expression of Long Non-Coding Rna H19 in Endometrial Cancer, Medical Journal of the Islamic Republic of Iran (2021)
5. The Potential Therapeutic Impact of Metformin in Glioblastoma Multiforme, Current Medicinal Chemistry (2023)
6. Long Non-Coding Rnas (Lncrnas); Roles in Tumorigenesis and Potentials As Biomarkers in Cancer Diagnosis, Experimental Cell Research (2022)
7. Metformin: Prevention of Genomic Instability and Cancer: A Review, Mutation Research - Genetic Toxicology and Environmental Mutagenesis (2018)
8. A Systematic Review of Long Non-Coding Rnas With a Potential Role in Breast Cancer, Mutation Research - Reviews in Mutation Research (2021)
Experts (# of related papers)
View all Related Experts
Farzad Masoud Kabir (2)
Hamid Reza Mirzaei (1)
Other Related Docs
9. Co-Treatment With Sulforaphane and Nano-Metformin Molecules Accelerates Apoptosis in Her2+ Breast Cancer Cells by Inhibiting Key Molecules, Nutrition and Cancer (2020)
10. Synergistic Anticancer Effects of Doxorubicin and Metformin Combination Therapy: A Systematic Review, Translational Oncology (2024)
11. New Insights Into the Long Non-Coding Rnas Dependent Modulation of Heart Failure and Cardiac Hypertrophy: From Molecular Function to Diagnosis and Treatment, Current Medicinal Chemistry (2024)
12. Constructing Mrna, Mirna, Circrna and Lncrna Regulatory Network by Analysis of Microarray Data in Breast Cancer, Gene Reports (2022)
13. The Effect of Metformin on Survival Outcomes of Non-Metastatic Breast Cancer Patients With Type 2 Diabetes, Asian Pacific Journal of Cancer Prevention (2021)
14. Effect of Metformin and Celecoxib on Cytotoxicity and Release of Gdf-15 From Human Mesenchymal Stem Cells in High Glucose Condition, Cell Biochemistry and Function (2017)
15. Evaluation of the Potential Role of Long Non-Coding Rna Linc00961 in Luminal Breast Cancer: A Case-Control and Systems Biology Study, Cancer Cell International (2020)
16. Impact of Metformin on the Therapeutic Effect of Radiotherapy, Radiation Medicine and Protection (2021)
17. Crosstalk Between Lncrnas in the Apoptotic Pathway and Therapeutic Targets in Cancer, Cytokine and Growth Factor Reviews (2022)
18. Regulation of Long Non-Coding Rnas by Plant Secondary Metabolites: A Novel Anticancer Therapeutic Approach, Cancers (2021)
19. Metformin As a Radiation Modifier; Implications to Normal Tissue Protection and Tumor Sensitization, Current Clinical Pharmacology (2019)
20. Role of Long Noncoding Rnas in Pathological Cardiac Remodeling After Myocardial Infarction: An Emerging Insight Into Molecular Mechanisms and Therapeutic Potential, Biomedicine and Pharmacotherapy (2024)
21. Long Noncoding Rnas Biomarker-Based Cancer Assessment, Journal of Cellular Physiology (2019)
22. A Systematic Review of the Effects of Ketogenic Diet on Treatment Outcomes and Quality of Life in Breast Cancer Patients, Iranian Journal of Obstetrics# Gynecology and Infertility (2023)
23. Deciphering the Oncogenic Landscape: Unveiling the Molecular Machinery and Clinical Significance of Lncrna Tmpo-As1 in Human Cancers, Pathology Research and Practice (2024)
24. Cardiovascular Disease and Cancer: Evidence for Shared Disease Pathways and Pharmacologic Prevention, Atherosclerosis (2017)
25. The Effects of Metformin and Pcl-Sorafenib Nanoparticle Co-Treatment on Mcf-7 Cell Culture Model of Breast Cancer, Naunyn-Schmiedeberg's Archives of Pharmacology (2024)
26. The Obesity-Autophagy-Cancer Axis: Mechanistic Insights and Therapeutic Perspectives, Seminars in Cancer Biology (2024)
27. Clinicopathological and Prognostic Value of Lncrna Pandar Expression in Solid Tumors: Evidence From a Systematic Review and Meta-Analysis, Journal of Cellular Physiology (2019)
28. Expression Analysis of Long Non-Coding Rnas Related With Foxm1, Gata3, Foxa1 and Esr1 in Breast Tissues, Frontiers in Oncology (2021)
29. The Role of Noncoding Rnas in Pituitary Adenoma, Epigenomics (2021)
30. Natural Products and the Balancing Act of Autophagy-Dependent/Independent Ferroptosis in Cancer Therapy, Naunyn-Schmiedeberg's Archives of Pharmacology (2024)
31. Non-Coding Rnas and Brain Tumors: Insights Into Their Roles in Apoptosis, Frontiers in Cell and Developmental Biology (2022)
32. Long Non-Coding Rnas As Epigenetic Regulators in Cancer, Current Pharmaceutical Design (2019)
33. Enhancement of Targeted Therapy in Combination With Metformin on Human Breast Cancer Cell Lines, Cell Communication and Signaling (2024)
34. Potential Roles of Endothelial Cells-Related Non-Coding Rnas in Cardiovascular Diseases, Pathology Research and Practice (2023)
35. Metformin for Cardiovascular Protection, Inflammatory Bowel Disease, Osteoporosis, Periodontitis, Polycystic Ovarian Syndrome, Neurodegeneration, Cancer, Inflammation and Senescence: What Is Next?, ACS Pharmacology and Translational Science (2021)
36. The Expression of Lncrnas Casc2, Neat1, Linc00299 in Breast Cancer Tissues and Their Relationship With the Xbp1 Splicing Rate in Iranian Patients During 2014–2019: A Cross-Sectional Study, Health Science Reports (2023)
37. Potential Roles of Lncrna-Xist/Mirnas/Mrnas in Human Cancer Cells, Clinical and Translational Oncology (2023)
38. A Comprehensive Insight Into the Correlation Between Ncrnas and the Wnt/Β-Catenin Signalling Pathway in Gastric Cancer Pathogenesis, Cell Communication and Signaling (2023)
39. Down-Regulation of Meg3, Panda and Casc2 As P53-Related Lncrnas in Breast Cancer, Breast Disease (2022)
40. Potential Roles of Long Noncoding Rnas As Therapeutic Targets in Organ Transplantation, Frontiers in Immunology (2022)
41. Role of Non-Coding Rnas in Neuroblastoma, Cancer Gene Therapy (2023)
42. The Effect of Metformin on Biomarkers Associated With Breast Cancer Outcomes: A Systematic Review, Meta-Analysis, and Dose–Response of Randomized Clinical Trials, Clinical and Translational Oncology (2020)
43. Innovative Targets of the Lncrna-Mir-Mrna Network in Response to Low-Dose Aspirin in Breast Cancer Patients, Scientific Reports (2022)